Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 23745526)

Published in J Aerosol Med Pulm Drug Deliv on June 08, 2013

Authors

Donald A Mahler1, Laurie A Waterman, Joseph Ward, Alex H Gifford

Author Affiliations

1: Geisel School of Medicine at Dartmouth , Hanover, NH; and Section of Pulmonary & Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

Associated clinical trials:

Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease | NCT01391559

Articles citing this

A review of nebulized drug delivery in COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75

Articles by these authors

Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry. Ann Intern Med (2014) 2.15

Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. COPD (2004) 1.58

What is the role of serological testing between stages of two-stage reconstruction of the infected prosthetic knee? Clin Orthop Relat Res (2011) 1.27

Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest (2009) 1.23

Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome (2013) 1.23

Noninvasive Ventilation Plus Extracorporeal CO2 Removal in High-Risk Conditions: A Forthcoming Tool? Crit Care Med (2015) 1.08

Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest (2007) 1.03

Comparison of continuous and discrete measurements of dyspnea during exercise in patients with COPD and normal subjects. Chest (2004) 0.94

Longitudinal changes in patient-reported dyspnea in patients with COPD. COPD (2012) 0.85

Early mortality of very low-birthweight infants at Queen Elizabeth Central Hospital, Malawi. Paediatr Int Child Health (2013) 0.83

Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler. J Aerosol Med Pulm Drug Deliv (2012) 0.82

Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD. COPD (2011) 0.81

Stability of dyspnea ratings after exercise training in patients with COPD. Med Sci Sports Exerc (2003) 0.81

Advantages of endurance treadmill walking compared with cycling to assess bronchodilator therapy. Chest (2009) 0.78

Perceptual and physiologic responses during treadmill and cycle exercise in patients with COPD. Chest (2008) 0.77

Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD. Med Sci Sports Exerc (2005) 0.77

Prospective Use of Descriptors of Dyspnea to Diagnose Common Respiratory Diseases. Chest (2015) 0.77

Failure of high-flow nasal cannula and delayed intubation: a new harmful sequence? Intensive Care Med (2015) 0.75

Responsiveness of patient-reported breathlessness during exercise in persistent asthma. Chest (2007) 0.75

Continuous ratings of breathlessness during exercise by children and young adults with asthma and healthy controls. Pediatr Pulmonol (2006) 0.75

Effect of increased blood levels of β-endorphin on perception of breathlessness. Chest (2013) 0.75